Breaking News

Parexel Joins Exostar’s Life Sciences Community

By Kristin Brooks | March 11, 2014

Aims to expedite collaborations, reduce costs, and accelerate R&D

Parexel has joined Exostar’s Life Sciences Identity Hub, a community of more than 500 organizations that brings CROs, pharmaceutical manufacturers, and academic institutions together to help facilitate collaborations, reduce capital and operating expenditures, and enhance productivity in speeding time-to-market.
 
Through its Secure Access Manager (SAM) service offering, organizations connect to the cloud-based Exostar Life Sciences Identity Hub, opening the door to external partner collaboration through portals, applications, and information sharing. SAM verifies identities of individuals and permits access based on authentication methods and permissions defined by asset owners.  
 
“Parexel is committed to providing solutions that help its customers expedite time-to-market and achieve peak market penetration,” said Tom Johnson, Exostar’s senior director of Security and Collaboration Solutions for Life Sciences. “Our community allows them to more effectively achieve these objectives by creating a connected, integrated environment where intelligence can be shared seamlessly and securely.”
 

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important